Skip to content

Infants With Agenesis of the Corpus Callosum

Outcome of Infants With Prenatal Corpus Callosum Agenesis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02267161
Acronym
DACCI
Enrollment
72
Registered
2014-10-17
Start date
2015-09-26
Completion date
2022-01-11
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agenesis of the Corpus Callosum

Keywords

agenesis, corpus callosum, prenatal diagnosis

Brief summary

The purpose of this study is to assess the neurological development at three years of age of children born after prenatal diagnosis of "isolated" agenesis of the corpus callosum.

Detailed description

Agenesis of the corpus callosum is the most frequent brain malformation. This anomaly may be diagnosed by ultrasound screening. In half of these prenatal cases, the anomaly seems to be isolated. In this setting, there are no prospective data concerning the development of these children, preventing any clear information to be delivered to parents. Prenatal diagnostic centers therefore face extremely variable rates of termination of pregnancies (TOP), which can reach up to 80%. This is a multicentric prospective interventional study whose primary objective is to assess the neurological development at three years of age of children born after prenatal diagnosis of "isolated" agenesis of the corpus callosum. Evaluation at three years will include Intellectual Quotient (IQ) quantification using the WPPSI-III, 3rd edition of Wechsler Preschool and Primary Scale of Intelligence and evaluation of intra-hemispheric coordination using the Vineland adaptative behaviour scale. Secondary objectives will include: * Circumstances leading to the prenatal diagnosis of agenesis of the corpus callosum * Causes leading to termination of pregnancies * Determination of criteria allowing to confirm that agenesis of the corpus callosum is isolated (family history, imagery, genetics) These results could allow to determine the optimal prenatal management of such cases.

Interventions

OTHERPsychometric scales for infants at 3 years of age

WPPSI-III, VINELAND, CBCL, NEPSY

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnant women from 28 weeks of gestation * Complete agenesis of the corpus callosum * Partial agenesis of the corpus callosum * Abnormal corpus callosum (size, anatomy) As diagnosed by an expert ultrasound fetal brain examination.

Exclusion criteria

* age \< 18 years old * women who do not understand french * women not covered by the French social security system * refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
WPPSI-III (wechsler preschool and primary scale of intelligence) :evaluation of intellectual quotient ( questionnaire)3 yearsNeurodevelopment outcome

Secondary

MeasureTime frameDescription
Vineland adaptative behaviour scales (motricity capacity) : questionnaire3 yearsNeurodevelopment outcome
Nepsy : developmental neuropsychological assessment (capacity of coordination)3 yearsNeurodevelopment outcome
CBCL: Child Behavior Checklist (behaviour) : self administered questionnaire3 yearsNeurodevelopment outcome
Cerebral abnormalitiesup to 3 years

Countries

France

Contacts

PRINCIPAL_INVESTIGATORJean-Marie Jouannic, MD, PhD

Assistance Publique - Hôpitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026